Salem Investment Counselors’s Morgan Stanley MS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6.54M | Sell |
31,273
-193
| -0.6% | -$38.2K | 0.16% | 87 |
|
|
2026
Q1 | $5.18M | Buy |
31,466
+561
| +2% | +$97.1K | 0.15% | 92 |
|
|
2025
Q4 | $5.49M | Buy |
30,905
+314
| +1% | +$52.4K | 0.15% | 88 |
|
|
2025
Q3 | $4.86M | Buy |
30,591
+307
| +1% | +$45.3K | 0.14% | 94 |
|
|
2025
Q2 | $4.27M | Sell |
30,284
-35
| -0.1% | -$4.3K | 0.14% | 97 |
|
|
2025
Q1 | $3.54M | Buy |
30,319
+1,002
| +3% | +$129K | 0.12% | 104 |
|
|
2024
Q4 | $3.69M | Sell |
29,317
-91
| -0.3% | -$11.2K | 0.12% | 106 |
|
|
2024
Q3 | $3.07M | Sell |
29,408
-134
| -0.5% | -$13.5K | 0.09% | 121 |
|
|
2024
Q2 | $2.87M | Buy |
29,542
+92
| +0.3% | +$8.76K | 0.09% | 122 |
|
|
2024
Q1 | $2.77M | Buy |
29,450
+2,234
| +8% | +$197K | 0.09% | 125 |
|
|
2023
Q4 | $2.54M | Buy |
27,216
+1,259
| +5% | +$101K | 0.09% | 118 |
|
|
2023
Q3 | $2.12M | Buy |
25,957
+2,777
| +12% | +$241K | 0.08% | 124 |
|
|
2023
Q2 | $1.98M | Buy |
23,180
+606
| +3% | +$51.8K | 0.07% | 130 |
|
|
2023
Q1 | $1.98M | Buy |
22,574
+10,432
| +86% | +$974K | 0.08% | 126 |
|
|
2022
Q4 | $1.03M | Sell |
12,142
-334
| -3% | -$28.5K | 0.04% | 175 |
|
|
2022
Q3 | $986K | Buy |
12,476
+360
| +3% | +$30.3K | 0.04% | 175 |
|
|
2022
Q2 | $922K | Buy |
12,116
+395
| +3% | +$32.4K | 0.04% | 186 |
|
|
2022
Q1 | $1.02M | Sell |
11,721
-242
| -2% | -$23.3K | 0.04% | 188 |
|
|
2021
Q4 | $1.17M | Buy |
11,963
+5,817
| +95% | +$579K | 0.04% | 172 |
|
|
2021
Q3 | $598K | Buy |
6,146
+70
| +1% | +$6.94K | 0.03% | 226 |
|
|
2021
Q2 | $557K | Hold |
6,076
| – | – | 0.03% | 228 |
|
|
2021
Q1 | $472K | Buy |
6,076
+675
| +12% | +$51.7K | 0.03% | 213 |
|
|
2020
Q4 | $370K | Sell |
5,401
-50
| -0.9% | -$2.87K | 0.02% | 229 |
|
|
2020
Q3 | $264K | Buy |
5,451
+50
| +0.9% | +$2.52K | 0.02% | 226 |
|
|
2020
Q2 | $261K | Buy |
5,401
+755
| +16% | +$31.7K | 0.02% | 222 |
|
|
2020
Q1 | $158K | Sell |
4,646
-434
| -9% | -$20.4K | 0.02% | 245 |
|
|
2019
Q4 | $260K | Hold |
5,080
| – | – | 0.02% | 227 |
|
|
2019
Q3 | $217K | Buy |
5,080
+800
| +19% | +$34.2K | 0.02% | 237 |
|
|
2019
Q2 | $188K | Sell |
4,280
-9,915
| -70% | -$442K | 0.02% | 250 |
|
|
2019
Q1 | $661K | Sell |
14,195
-15
| -0.1% | -$631 | 0.07% | 143 |
|
|
2018
Q4 | $563K | Buy |
14,210
+15
| +0.1% | +$655 | 0.07% | 133 |
|
|
2018
Q3 | $661K | Sell |
14,195
-870
| -6% | -$42.5K | 0.07% | 143 |
|
|
2018
Q2 | $714K | Sell |
15,065
-600
| -4% | -$31.4K | 0.07% | 136 |
|
|
2018
Q1 | $830K | Sell |
15,665
-50
| -0.3% | -$2.77K | 0.09% | 125 |
|
|
2017
Q4 | $825K | Buy |
15,715
+2,290
| +17% | +$116K | 0.09% | 128 |
|
|
2017
Q3 | $652K | Buy |
13,425
+1,038
| +8% | +$48.1K | 0.08% | 135 |
|
|
2017
Q2 | $552K | Sell |
12,387
-1,628
| -12% | -$70.2K | 0.06% | 157 |
|
|
2017
Q1 | $591K | Buy |
14,015
+1,649
| +13% | +$73.2K | 0.06% | 173 |
|
|
2016
Q4 | $522K | Buy |
12,366
+8,933
| +260% | +$338K | 0.06% | 171 |
|
|
2016
Q3 | $1.1K | Buy |
+3,433
| New | +$102K | 0.01% | 255 |
|
Other funds holding MS
HCM
ATO
OIAM
AAMU
DLA
RG
Salem Investment Counselors's MS Position: Q2 2026 in Review
Salem Investment Counselors reduced its Morgan Stanley (MS) stake by 0.61% in Q2 2026, selling an estimated $38.2K and leaving 31,273 shares worth $6.54M. The position accounts for 0.16% of the portfolio, ranked #87.
Salem Investment Counselors first reported a position in MS in Q3 2016 and has held it in 40 quarters since. 863 funds tracked by Wall St. Rank hold MS as of Q2 2026.
- Salem Investment Counselors held 31,273 shares of Morgan Stanley worth $6.54M as of Q2 2026.
- Salem Investment Counselors sold 193 Morgan Stanley shares in Q2 2026, an estimated $38.2K.
- Morgan Stanley made up 0.16% of Salem Investment Counselors's portfolio in Q2 2026, its #87 holding.
- Salem Investment Counselors first reported a position in Morgan Stanley in Q3 2016 and has held it in 40 quarters since.
- 863 funds tracked by Wall St. Rank held Morgan Stanley as of Q2 2026.
Based on Salem Investment Counselors's 13F filing for Q2 2026, filed 14 Jul 2026.